3883 |
MGIT 960 Culture Detection Time Frame |
04/06/2024 |
Laboratory services and management |
3885 |
Reading MGIT 960 Tubes Manually |
04/06/2024 |
Laboratory services and management |
3887 |
MTB growth characteristics and morphology |
04/06/2024 |
Laboratory services and management |
3888 |
AFB Smears from Liquid Culture |
04/06/2024 |
Laboratory services and management |
3889 |
Rapid Antigen Detection/Immunochromatographic Assay for MTB |
04/06/2024 |
Laboratory services and management |
3890 |
Procedure for Immunochromatographic Test SD Bioline Assay/Capillia/TBcID |
04/06/2024 |
Laboratory services and management |
3891 |
Inoculum Preparation for Immunochromatographic Test SD Bioline Assay/Capillia/TBcID |
04/06/2024 |
Laboratory services and management |
3892 |
Results interpretation for Immunochromatographic Test SD Bioline Assay/Capillia/TBcID |
04/06/2024 |
Laboratory services and management |
3893 |
Internal Quality Control Kits for Immunochromatographic Test SD Bioline Assay/Capillia/TBcID |
04/06/2024 |
Laboratory services and management |
3896 |
Niacin production test for MTB |
04/06/2024 |
Laboratory services and management |
3897 |
Nitrate reduction test for MTB |
04/06/2024 |
Laboratory services and management |
3899 |
Storage of Culture Isolates |
04/06/2024 |
Laboratory services and management |
3900 |
Media and consumables required to store culture isolates |
04/06/2024 |
Laboratory services and management |
3901 |
Preparation of Selective Middlebrook- 7H9 Liquid Medium |
04/06/2024 |
Laboratory services and management |
3902 |
Quality Control of Selective Middlebrook- 7H9 Liquid Medium |
04/06/2024 |
Laboratory services and management |
3903 |
Inoculation Procedure for Storage of Culture Isolates |
04/06/2024 |
Laboratory services and management |
3904 |
Sterility Check of Culture Isolates |
04/06/2024 |
Laboratory services and management |
3906 |
Revival of the Frozen Cultures |
04/06/2024 |
Laboratory services and management |
3909 |
Drug Susceptibility Methods |
04/06/2024 |
Laboratory services and management |
3912 |
Preparing the Isolate for DST |
04/06/2024 |
Laboratory services and management |
3913 |
Preparing the Isolate for Liquid Culture DST |
04/06/2024 |
Laboratory services and management |
3915 |
Critical Concentrations and Reconstitution of SIRE Drugs |
04/06/2024 |
Laboratory services and management |
3917 |
Critical Concentration and Reconstitution of PZA |
04/06/2024 |
Laboratory services and management |
3918 |
Second-line Phenotypic Drug Susceptibility Testing |
04/06/2024 |
Laboratory services and management |
3919 |
Critical Concentration and formulations of Second-line Anti-TB Drugs for DST |
04/06/2024 |
Laboratory services and management |
3920 |
Preparation and Storage of Second-line Anti-TB Drugs used for DST |
04/06/2024 |
Laboratory services and management |
3921 |
Inoculum Preparation for First and Second-line Phenotypic DST |
04/06/2024 |
Laboratory services and management |
3922 |
Inoculum Preparation from MGIT Positive Culture |
04/06/2024 |
Laboratory services and management |
3923 |
Inoculation of Growth Control Tube/Drug Containing Tubes |
04/06/2024 |
Laboratory services and management |
3924 |
PZA Inoculum Preparation |
04/06/2024 |
Laboratory services and management |